{ "case_number": "CAC-UDRP-108364", "time_of_filling": "2026-01-27 10:10:40", "domain_names": [ "novartis-ag.xyz" ], "case_administrator": "Olga Dvořáková (Case admin)", "complainant": [ " Novartis AG" ], "complainant_representative": "Abion GmbH", "respondent": [ "Nhla Nhla (Nhla associates )" ], "respondent_representative": null, "factual_background": "

The disputed domain name was registered on January 15, 2026. By the time of the rendering of this Decision, the disputed domain name does not resolve to an active website, but to an error page instead. The Complainant, however, has demonstrated that at some point before the filing of the Complaint, e.g. on January 23, 2026, the disputed domain name resolved to a typical “Pay-per-click” (“PPC”) website, displaying relevant sponsored links that related to the pharmaceutical industry such as “List of Pharmaceutical Products”, “Clinical Research Backed Medications”, “Prescription Medications And Therapies”, “Innovative Health Solutions Online” and “Buy Pharmaceutical Products”.<\/p>", "other_legal_proceedings": "

The Panel is not aware of any other legal proceedings which are pending or decided, and which relate to the disputed domain name.<\/p>", "no_response_filed": "

The Complainant contends that the requirements of the Policy have been met and that the disputed domain name should be transferred to it.<\/p>\n

No administrative compliant response has been filed.  <\/p>", "rights": "

The Complainant has, to the satisfaction of the Panel, shown the disputed domain name is identical or confusingly similar to a trademark or service mark in which the Complainant has rights (within the meaning of paragraph 4(a)(i) of the Policy).<\/p>", "no_rights_or_legitimate_interests": "

The Complainant has, to the satisfaction of the Panel, shown the Respondent to have no rights or legitimate interests in respect of the disputed domain name (within the meaning of paragraph 4(a)(ii) of the Policy).<\/p>", "bad_faith": "

The Complainant has, to the satisfaction of the Panel, shown the disputed domain name has been registered and is being used in bad faith (within the meaning of paragraph 4(a)(iii) of the Policy).<\/p>", "procedural_factors": "

The Panel is satisfied that all procedural requirements under UDRP were met and there is no other reason why it would be inappropriate to provide a decision.<\/p>", "decision": "Accepted", "panelists": [ "Stephanie Hartung" ], "date_of_panel_decision": "2026-03-05 00:00:00", "informal_english_translation": "

The Complainant has evidenced to be the owner of various trademarks relating to its company name and brand NOVARTIS, including, but not limited to the following:<\/p>\n